Neuroone Medical Technologies (NMTC) FCF Margin (2010 - 2026)
Neuroone Medical Technologies (NMTC) posted FCF Margin of 73.43% for Q1 2026, up 32.71% on a QoQ basis from 109.13% in Q4 2025, and down 6915.0% year-over-year from 1.08% in Q1 2025.
Neuroone Medical Technologies (NMTC) FCF Margin (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies' FCF Margin history runs 13 years deep, the most recent figure standing at 73.43% for Q1 2026.
- Quarterly FCF Margin fell 6915.0% year-over-year to 73.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 82.33% (up 371.0% YoY) and the FY2025 annual result came in at 32.09%, up 29030.0% from the prior year.
- FCF Margin was 73.43% for Q1 2026 at Neuroone Medical Technologies, up from 109.13% in the prior quarter.
- Across five years, FCF Margin topped out at 1383.43% in Q3 2022 and bottomed at 9061.09% in Q1 2022.
- A 5-year average of 1351.74% and a median of 287.63% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin slumped 261163 bps — and 2023, when it jumped 826156 bps.
- Neuroone Medical Technologies' FCF Margin stood at 3057.95% in 2022, then soared by 87 bps to 393.45% in 2023, then soared by 101 bps to 5.61% in 2024, then tumbled by 2046 bps to 109.13% in 2025, then jumped by 33 bps to 73.43% in 2026.
- Business Quant data shows NMTC's FCF Margin at 73.43% in Q1 2026, 109.13% in Q4 2025, and 56.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | -73.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.43% |
| Dec 31, 2025 | -109.13% |
| Sep 30, 2025 | -56.05% |
| Jun 30, 2025 | -88.86% |
| Mar 31, 2025 | -4.28% |
| Dec 31, 2024 | 5.61% |
| Sep 30, 2024 | -993.00% |
| Jun 30, 2024 | -287.63% |
| Mar 31, 2024 | -160.21% |
| Dec 31, 2023 | -393.45% |
| Sep 30, 2023 | -399.10% |
| Jun 30, 2023 | -488.89% |
| Mar 31, 2023 | -799.53% |
| Dec 31, 2022 | -3,057.95% |
| Sep 30, 2022 | 1,383.43% |
| Jun 30, 2022 | -8,396.07% |
| Mar 31, 2022 | -9,061.09% |
| Dec 31, 2021 | -8,120.86% |
| Sep 30, 2021 | -4,270.97% |
| Jun 30, 2021 | -5,784.44% |